The Translational Efficacy Gap
Why interventions extending murine lifespan by 20%+ frequently fail to show significance in Phase II human trials. An analysis of the standard ITP models vs human metabolic realities.
Read Full ReportClinical trial tracking, biomarker validation, and meta-analyses of geroprotective interventions.
Why interventions extending murine lifespan by 20%+ frequently fail to show significance in Phase II human trials. An analysis of the standard ITP models vs human metabolic realities.
Read Full ReportA definitive list of the 14 clinical biomarkers most strongly correlated with reduced all-cause mortality and delayed biological aging, including target ranges for optimization.
View Biomarker Index